Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT04458883

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT04458883.

📅 01 May 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT04458883
Sponsor
University of Aberdeen
Start
2020-08-01
ClinicaliQ Trial Snapshot
  • The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT04458883.
  • What is being tested: Development and clinical validation of a custom-built cardiac coil designed specifically for a whole-body Field-Cycling MRI (FFC-MRI) prototype to enable cardiac imaging in human subjects.
  • Patient eligibility overview: Human subjects deemed suitable for cardiac MRI scanning; specific inclusion/exclusion criteria would typically encompass standard cardiac imaging contraindications (pacemakers, metallic implants) and relevant cardiac or general health status requirements.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The main aim of the study is to build and test a cardiac-specific coil purposely assembled in house to suit the FFC-MRI whole-body prototype and to test if it could be used for clinical cardiac scans in human subject populations.

Eligibility Snapshot
  • : * Participant who is willing and able to give informed consent for participation in the study * Healthy volunteers willing to give informed consent for participation in the study * Patients diagnosed with a previous myocardial infarction

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity
Cardiology / Cardiovascular · 07 May 2026
Semaglutide is recommended for adults with established cardiovascular disease and overweight/obesity to reduce major adverse cardiovascular events – consider prescribing as part…
View guideline →
Guideline
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
Cardiology / Cardiovascular · 30 Mar 2026
Covers indications for cardiac pacing and cardiac resynchronization therapy (CRT) • Provides guidance on device selection, implantation techniques, and optimization • Addresses…
View guideline →
Clinical Brief
Women’s voices to be at the heart of renewed health strategy
Cardiology / Cardiovascular · NHS England · 14 Apr 2026
Women's Health Strategy will be renewed with enhanced mechanisms to centre female patient voices in healthcare planning and delivery Strategy aims to…
View brief →
Guideline
2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
Cardiology / Cardiovascular · 30 Mar 2026
Covers risk stratification for sudden cardiac death and indications for ICD implantation • Provides management recommendations for ventricular tachycardia and ventricular fibrillation…
View guideline →
Guideline
Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock
Cardiology / Cardiovascular · 25 Mar 2026
Percutaneous insertion of catheter-based left ventricular microaxial flow pumps may be considered for patients with acute cardiogenic shock refractory to medical therapy…
View guideline →
Clinical Brief
Weight-loss jabs will be offered on NHS for people at risk of further heart attacks
Cardiology / Cardiovascular · BBC Health · 31 Mar 2026
GLP-1 receptor agonists (weight-loss jabs) will now be offered on NHS to over 1 million people in England at high cardiovascular risk,…
View brief →